166 related articles for article (PubMed ID: 17400065)
21. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
22. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
23. Immunobiology of muscle: advances in understanding an immunological microenvironment.
Wiendl H; Hohlfeld R; Kieseier BC
Trends Immunol; 2005 Jul; 26(7):373-80. PubMed ID: 15922662
[TBL] [Abstract][Full Text] [Related]
24. [Importance of HLA-G in therapy of cancer].
Zidi I; Bartegi A
Therapie; 2008; 63(4):327-32. PubMed ID: 18937912
[TBL] [Abstract][Full Text] [Related]
25. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.
Mrass P; Weninger W
Immunol Rev; 2006 Oct; 213():195-212. PubMed ID: 16972905
[TBL] [Abstract][Full Text] [Related]
26. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
[TBL] [Abstract][Full Text] [Related]
27. [The immune status of the central nervous system].
de Micco C; Toga M
Rev Neurol (Paris); 1988; 144(12):776-88. PubMed ID: 3070691
[TBL] [Abstract][Full Text] [Related]
28. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous expression of HLA-G1, -G2, -G5, -G6, and -G7 in myeloid and plasmacytoid dendritic cells isolated from umbilical cord blood.
Román A; Rodríguez M; Herraiz MA; Jordá J; Cervera I; Peñaloza J; Vidart JA; Martinez-Laso J
Hum Immunol; 2009 Feb; 70(2):104-9. PubMed ID: 19135113
[TBL] [Abstract][Full Text] [Related]
31. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
[TBL] [Abstract][Full Text] [Related]
32. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G.
Airas L; Nikula T; Huang YH; Lahesmaa R; Wiendl H
J Neuroimmunol; 2007 Jul; 187(1-2):205-11. PubMed ID: 17561269
[TBL] [Abstract][Full Text] [Related]
33. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen-G and cancer immunoediting.
Urosevic M; Dummer R
Cancer Res; 2008 Feb; 68(3):627-30. PubMed ID: 18245459
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
[TBL] [Abstract][Full Text] [Related]
36. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
37. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
38. Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression.
Veit TD; Chies JA
Transpl Immunol; 2009 Mar; 20(4):229-31. PubMed ID: 19038339
[TBL] [Abstract][Full Text] [Related]
39. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
Dragun D
Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
[TBL] [Abstract][Full Text] [Related]
40. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
Sumitran-Holgersson S
Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
